Fritz hoffmann-la roche biography of christopher
•
Abstract
This paper looks at the commodification of interferon, marketed by Hoffmann La Roche (short: Roche) as Roferon A in , as a case study that helps us understand the role of pharmaceutical industry in cancer research, the impact of molecular biology on cancer therapy, and the relationships between biotech start-ups and established pharmaceutical firms. Drawing extensively on materials from the Roche company archives, the paper traces interferon’s trajectory from observed phenomenon (viral interference) to product (Roferon A). Roche embraced molecular biology in the late s to prepare for the moment when the patents on some of its bestselling drugs were going to expire. The company funded two basic science institutes to gain direct access to talents and scientific leads. These investments, I argue, were crucial for Roche’s success with recombinant interferon, along with more mundane, technical and regulatory know-how held at Roche’s Nutley base. The paper analyses in some detai
•
A history of Roche
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine.
Roche was found in by a man called Fritz Hoffmann-La Roche. The visionary founder was “among the first to recognise that the industrial manufacture of standardized medicines would be a major advance in the fight against disease”. He focused his company on innovation and establishing an international presence.
Today, Roche is headquartered in Basel, Switzerland. The company now employs 80, people across a number of pharmaceutical and diagnostic sites across the world.
The first of many successes
Roche was founded during the industrial revolution. Fritz wasted no time in starting to fulfil his goal of international expansion, beginning with moving all manufacturing to his expanded production facility in Grenzach, Germany between and Along with his new partner, C
•
Christopher Suchet
Genentech, Inc.
Pharmaceuticals: MajorHealth Technology
Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in and is headquartered in South San Francisco, CA.